Sulfasalazine for Inflammatory Bowel Disease User Reviews
Brand names: Azulfidine, Azulfidine EN-tabs
Sulfasalazine has an average rating of 7.5 out of 10 from a total of 4 reviews for the treatment of Inflammatory Bowel Disease. 75% of reviewers reported a positive experience, while 25% reported a negative experience.
- Sooz
- Taken for 1 to 6 months
- March 14, 2023
"I have taken this medication for several months now. I did not have any side effects from it. It was easy to take, although it could be smaller. I do not take it now because it has been discontinued. My doctor is now looking for an affordable replacement. Does anyone know why was it discontinued?"
- Washi...
- Taken for 1 to 6 months
- March 27, 2014
Sulfazine (sulfasalazine) "In remission all labs and inflamatory markers normal. No side effects other than a headache once in a while."
- Dee
- January 26, 2022
"I took sulfasalazine and within 30 days broke out all over with itching and fever. Finally was diagnosed with DRESS Syndrome."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Inflammatory Bowel Disease
Care guides
Medicine.com guides (external)
More about sulfasalazine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (194)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: 5-aminosalicylates
- Breastfeeding
- En español
Patient resources
Other brands
Azulfidine, Sulfazine, Azulfidine EN-tabs
Professional resources
Other brands
Azulfidine, Azulfidine EN-tabs
"My constant infections from Mycoplasma infections are a thing of the past. This medicine has kept intestinal leakage and polyps from recurring, keeps the blood in my urine to a minimum and constant kidney infections from recurring."